PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Kidney Cancer Research Bureau, Mayakovskogo pereulok 2, Moscow, 109147, Russia. tsimafeyeu@gmail.com.\', \'N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.\', \'Pacific State Medical University, Vladivostok, Russia.\', \'N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia.\', \'St. Alexei Central Clinical Hospital, Moscow, Russia.\', \'Ivanovo Regional Oncology Dispensary, Ivanovo, Russia.\', \'V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.\', \'Medicine 24/7 Clinic, Moscow, Russia.\', \'Saint-Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological), St. Petersburg, Russia.\', \'Ulyanovsk Regional Cancer Center, Ulyanovsk, Russia.\', \'Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13045-021-01205-z
?:hasPublicationType
?:journal
  • Journal of hematology & oncology
is ?:pmid of
?:pmid
?:pmid
  • 34774086
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34774086>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34774086>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all